Lv3
210 积分 2024-10-28 加入
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1 -Mutated Acute Myeloid Leukemia
22小时前
已完结
Hypomethylating agents for elderly patients with acute myeloid leukemia: a PRISMA systematic review and meta-analysis
20天前
已完结
A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T‐cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T‐cell therapy
23天前
已完结
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
1个月前
已完结
Towards precision medicine for AML
1个月前
已完结
Acute myeloid leukemia: Incidence, transplantation and survival through Italian administrative healthcare data
1个月前
已完结
Clinical and Therapeutic Implications of Cancer Stem Cells
1个月前
已完结
Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy
1个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1个月前
已完结
Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022
1个月前
已完结
皖公网安备34019202002308
